Titration of flumazenil during awake craniotomy

Sato T, Nishiwaki K. Remimazolam should be antagonized by an adequate flumazenil. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03117-9. Murata H, Yokoyama A, Hara T. Remimazolam and low-dose flumazenil for awake craniotomy. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03103-1. Sato T, Nishiwaki K. Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study. J Anesth. 2022;36(1):152–5. Yoshida A, Kurata S, Kida K, Tsubokawa T. Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil. JA Clin Rep. 2021;7(1):14. Masui K. Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03107-x.